Loading...
Loading...
Among the 8 tracked institutional investors we monitor, OCUL (OCULAR THERAPEUTIX INC) is held with a combined value of $660.08M across 72,916,002 shares. The largest holder is FMR LLC with a position worth $276.58M (0.01% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 5 funds increased their holdings. 2 funds reduced their position.
Total Institutional Value
$660.08M
Total Shares Held
72,916,002
Institutional Holders
8
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | FMR LLC | $276.58M | 0.01% | +2.7% |
| 2 | VANGUARD GROUP INC | $140.52M | 0.00% | New |
| 3 | BlackRock, Inc. | $136.65M | 0.00% | +3.4% |
| 4 | Point72 Asset Management, L.P. | $46.88M | 0.06% | +444.6% |
| 5 | STATE STREET CORP | $39.88M | 0.00% | +12.2% |
| 6 | RENAISSANCE TECHNOLOGIES LLC | $9.72M | 0.02% | +45.1% |
| 7 | CITADEL ADVISORS LLC | $9.56M | 0.00% | -61.2% |
| 8 | MILLENNIUM MANAGEMENT LLC | $288.03K | 0.00% | -99.0% |
As of the latest SEC 13F filings, FMR LLC is the largest institutional holder of OCUL with a position worth $276.58M, representing 0.01% of their portfolio. In total, 8 institutional investors hold OCUL with a combined value of $660.08M.
In the most recent quarter, 1 fund opened a new position in OCUL. Additionally, 5 increased their holdings and 2 reduced their positions.
Institutional investors hold $660.08M worth of OCUL stock across 8 positions. The largest institutional holder is FMR LLC with $276.58M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For OCUL, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their OCUL positions.